Target intelligence / Profile preview

Collagen (types I and III)

Molecular classification
Other (Structural ECM protein)
01

Overview

Collagen is the primary structural protein in the extracellular matrix (ECM) of skin and most connective tissues, with types I and III being the main forms involved in tissue repair. After injury, fibroblasts secrete new collagen to replace damaged matrix, providing a scaffold for cell migration, re-epithelialization, neovascularization, and tissue remodeling. The proportions of collagen types change dynamically during healing, influencing tissue strength and function. Matrix metalloproteinases (MMPs) and other enzymes regulate collagen deposition and degradation; imbalances can result in either chronic wounds or pathological fibrosis/scarring. "Collagen matrix support for tissue repair" thus refers to the essential structural and functional roles of collagen ECM in orchestrating the processes of acute wound closure and tissue remodeling, rather than a discrete druggable target[2][3][4]. In summary, "Collagen matrix support for tissue repair" is a biological process and not a canonical molecular target. It refers to the collective role of collagens (mainly types I and III) and associated matrix remodeling proteins in tissue repair, rather than a single entity that can be structurally or pharmacologically targeted.

Other names
Collagen matrixCollagen scaffoldExtracellular matrix collagenCollagen support
02

Mechanism of action

Drugs or devices may promote or enzymatically degrade the collagen matrix to enhance/remodel healing, or regulate cell migration and tissue regeneration[2][3].

03

Biological functions

Structural support for tissue integrityCell migration scaffoldRegulation of cell proliferation and differentiationMatrix for angiogenesis (blood vessel formation)Modulation of inflammation during wound healingSubstrate for enzymatic remodeling (e.g., by MMPs)
04

Disease associations

Impaired healing (chronic wounds)Fibrosis (excessive collagen deposition)Scar formationTissue regeneration defects
05

Safety considerations

Excessive collagen degradation leading to weak tissueFibrosis or scarring from excessive collagen depositionImmune/inflammatory reactions to non-autologous collagen sources
06

Interacting drugs

Collagenase (enzymatic debridement)

2 more in the full profile.

07

Biomarkers

Collagen type I/III expression ratios (for wound maturity)Levels of collagen degradation products (matricryptins like endostatin)MMP expression/activity (for collagen turnover assessment)[2][3]

Beyond the preview

Go deeper on Collagen (types I and III).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Collagen (types I and III).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call